From: Synthesis and therapeutic potential of imidazole containing compounds
Compounds | MIC (µM/ml) | ||||
---|---|---|---|---|---|
S. aureus | B. subtilis | E. coli | C. albicans | A. niger | |
18a | 0.030 | 0.030 | 0.030 | 0.060 | 0.030 |
18b | 0.060 | 0.030 | 0.030 | 0.030 | 0.030 |
18c | 0.030 | 0.030 | 0.030 | 0.030 | 0.030 |
18d | 0.028 | 0.014 | 0.028 | 0.028 | 0.028 |
18e | 0.031 | 0.031 | 0.031 | 0.031 | 0.031 |
18f | 0.030 | 0.030 | 0.030 | 0.030 | 0.030 |
18g | 0.030 | 0.015 | 0.015 | 0.030 | 0.030 |
18h | 0.031 | 0.031 | 0.031 | 0.031 | 0.031 |
18i | 0.027 | 0.027 | 0.013 | 0.027 | 0.027 |
18j | 0.029 | 0.029 | 0.015 | 0.007 | 0.029 |
18k | 0.058 | 0.029 | 0.007 | 0.029 | 0.029 |
18l | 0.028 | 0.028 | 0.028 | 0.028 | 0.028 |
18m | 0.061 | 0.030 | 0.030 | 0.030 | 0.030 |
18n | 0.031 | 0.031 | 0.008 | 0.031 | 0.031 |
18o | 0.029 | 0.029 | 0.029 | 0.029 | 0.029 |
18p | 0.027 | 0.027 | 0.027 | 0.027 | 0.027 |
18q | 0.030 | 0.030 | 0.030 | 0.030 | 0.030 |
18r | 0.028 | 0.028 | 0.028 | 0.028 | 0.028 |
Norfloxacin | 0.47 | 0.47 | 0.47 | – | – |
Fluconazole | – | – | – | 0.50 | 0.50 |